Michael J. Hadd,Michael D. Hocker,Mark W. Holladay,Gang Liu,Martin W. Rowbottom,Shimin Xu
申请号：
US15187656
公开号：
US09938261B2
申请日:
2016.06.20
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
